EMD Shares Emyria Limited
WATCH ASX · ASXDigital engagement platform offers speculative AI-enabled content and monetisation upside from a small base.
Signal breakdown
- ▸Highly speculative platform optionality with limited liquidity and confirmation.
- ▾Below 50-day MA (-13.68%)
- ▾Near 52-week low (7.1% of range)
Is EMD a buy right now?
Trend: EMD is trading below the 50-day average (-22.00%), RSI 46 — neutral momentum, with a 3-month return of -17.02%.
Valuation & quality: Emyria Limited trades on price-to-book 3.55; fundamentals show net margin -150.8%, return on equity -86.4%, revenue growth 239.3% year on year.
Our screen: WATCH (score 0) — Digital engagement platform offers speculative AI-enabled content and monetisation upside from a small base.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -20.00% | +25.00% | +0.00% | +0.00% | -20.00% |
Fundamentals
Technical signals
About Emyria Limited
Emyria Limited engages in delivering and developing of treatments for mental health and select neurological conditions in Australia. The company operates through Clinical Services and corporate segments. It provides therapy programs for post-traumatic stress disorder (PTSD) and treatment-resistant depression.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Artificial Intelligence picks
Browse: all ASX stocks · Artificial Intelligence picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.